Financial reports
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
1 Mar 22
Current reports
8-K
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook
28 Feb 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Silk Road Medical Reports Third Quarter 2023 Financial Results
8 Nov 23
8-K
Silk Road Medical Names Chas McKhann Chief Executive Officer
2 Nov 23
8-K
Silk Road Medical Announces Preliminary Third Quarter 2023 Revenue and Provides Revised 2023 Outlook
10 Oct 23
8-K
Departure of Directors or Certain Officers
15 Sep 23
8-K
Silk Road Medical Reports Second Quarter 2023 Financial Results
1 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
23 Jun 23
8-K
Silk Road Medical Reports First Quarter 2023 Financial Results
9 May 23
8-K
Departure of Directors or Certain Officers
15 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
28 Feb 24
S-3ASR
Automatic shelf registration
15 May 23
RW
Registration withdrawal request
12 May 23
S-3
Shelf registration
9 May 23
S-8
Registration of securities for employees
28 Feb 23
424B5
Prospectus supplement for primary offering
20 Oct 22
424B5
Prospectus supplement for primary offering
18 Oct 22
FWP
Free writing prospectus
17 Oct 22
S-8
Registration of securities for employees
1 Mar 22
S-8
Registration of securities for employees
1 Mar 21
Other
SD
Conflict minerals disclosure
30 May 23
SD
Conflict minerals disclosure
31 May 22
SEC STAFF
SEC staff action: Order
2 Apr 21
SEC STAFF
SEC staff action: Order
5 Mar 21
EFFECT
Notice of effectiveness
9 Aug 19
CORRESP
Correspondence with SEC
6 Aug 19
CORRESP
Correspondence with SEC
6 Aug 19
UPLOAD
Letter from SEC
9 Jul 19
CT ORDER
Confidential treatment order
4 Apr 19
CT ORDER
Confidential treatment order
4 Apr 19
Ownership
4
Kevin J. Ballinger
7 Mar 24
4
Lucas W. Buchanan
5 Mar 24
4
Richard Ruedy
5 Mar 24
4
Andrew S. Davis
5 Mar 24
4
Marie L. Jones
5 Mar 24
4
Chas McKhann
5 Mar 24
4
Kevin M Klemz
5 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
144
Notice of proposed sale of securities
5 Mar 24